Learn more about Race Oncology's board of directors and management team
Find out more about Race Oncology’s board of directors and management team.
Dr John Cullity
Phillip R Lynch
CEO & Director
Dr Daniel Tillett
Chief Scientific Officer & Director
Professor Borje Andersson
Chief Medical Officer and Director
L36, 1 Macquarie Place, Sydney
+61 2 8051 3043
Race Oncology is a specialty pharmaceutical company whose business model is to pursue later stage drug assets, principally in the cancer field. Our first important asset is a chemotherapy drug called Bisantrene.
Get the latest news and updates